세계의 당질체학 및 당쇄생물학 시장 보고서(2025년)

Glycomics or glycobiology encompasses the exploration of saccharides' structures, biosynthesis, and biological functions, delving into the intricate world of sugar chains or glycans widely present in natural systems. These glycans are thoroughly examined within the realm of glycobiology for their structural composition, production processes, and biological significance.

The primary products associated with glycomics or glycobiology include enzymes, kits, reagents and chemicals, instruments, and carbohydrates. Enzymes, as biological polymers, serve as catalysts for biochemical reactions. These products find application across various domains such as drug discovery and development, disease diagnostics, among others, and are extensively utilized within academic research institutes, pharmaceutical and biotechnology companies, as well as clinical laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The glycomics or glycobiology market research report is one of a series of new reports from The Business Research Company that provides glycomics or glycobiology market statistics, including glycomics or glycobiology industry global market size, regional shares, competitors with a glycomics or glycobiology market share, detailed glycomics or glycobiology market segments, market trends and opportunities, and any further data you may need to thrive in the glycomics or glycobiology industry. This glycomics or glycobiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification.

The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analytics, expansion in glycobiology-based drug development, integration of glycomics in disease biomarker discovery, personalized medicine, and glycan-based therapeutics. Major trends in the forecast period include cross-disciplinary collaborations, glycosylation patterns in disease mechanisms, innovative precision medicine and personalized therapies, advancements in glycoanalytical tools, glycans in immunotherapy and vaccines.

The forecast of 17.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of glycan analyzers and carbohydrate microarrays sourced from Germany and Japan, thereby delaying biomarker discovery for chronic diseases and elevating research laboratory expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The surge in demand for medications catering to severe chronic diseases is poised to drive the growth of the glycomics or glycobiology market. Chronic diseases, which persist over the long term without definitive cures, prompt extensive research into glycomics to understand glycosylation changes and their functional implications in drug development for these conditions. According to the American Cancer Society's Cancer Facts and Figures 2022-2024, the number of cancer survivors, considered a chronic disease, is projected to increase from 22.5 million in 2032 to an estimated 26 million by 2040. Hence, the escalating demand for medications to treat severe chronic diseases acts as a significant driver for the glycomics or glycobiology market.

The rising need for pharmaceutical products is expected to be a major driver for the growth of the glycomics or glycobiology market. These products encompass drugs specifically formulated to diagnose, prevent, treat, or cure various medical conditions. Glycomics and glycobiology play crucial roles in pharmaceutical development by elucidating disease mechanisms, identifying therapeutic targets, and optimizing drug design and effectiveness. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the total pharmaceutical production in Europe surged to $384,200 million (€340,000 million) in 2022, marking a significant 4.95% increase from the preceding year's $366,267 million (€323,950 million). Consequently, the heightened demand for pharmaceutical products acts as a catalyst propelling the glycomics or glycobiology market's growth.

A prevailing trend in the glycomics or glycobiology market is the emphasis on investments in research and development (R&D) endeavors. Prominent research institutions are channeling funding into glycobiology research centers, aiming to further advancements in glycomics or glycobiology. For instance, Griffith University's Institute for Glycomics unveiled the ACRF International center for Cancer Glycomics in August 2022. This pioneering facility, established with a $2.6 million ACRF grant, is dedicated to unraveling cancer glycocoding. It is envisioned as a unique resource, driving enhanced understanding of the glycocode and translating discoveries into clinical outcomes, ultimately improving the lives of cancer patients.

Leading companies within the glycomics or glycobiology market are innovating by developing cutting-edge products like glycan screening kits to cater to expanded customer bases and augment revenue streams. Glycan Screening Kits are specialized tools designed for comprehensive immunofluorescence detection of glycan expression in tissue sections, aiding researchers in characterizing complex glycans for insights into disease biomarkers and protein modifications. Vector Laboratories Inc., in July 2022, introduced its breakthrough product, the Glysite Scout Glycan Screening Kits. These fully integrated immunofluorescence kits offer robust capabilities for profiling glycan expression in tissue sections. The kits empower researchers to gain valuable insights into the significance of glycomics in samples, particularly in understanding post-translational protein modifications and disease biomarkers. With curated lectin selections, these kits enable the identification of major surface glycan motifs, enriching the understanding of disease progression, treatment impacts, and tissue characterization.

In October 2022, the Centre for Cellular and Molecular Platforms (C-CAMP), an India-based research foundation, entered into a partnership with Agilent Technologies, Inc. for an undisclosed amount. Through this collaboration, C-CAMP aims to enhance its portfolio by leveraging Agilent's expertise in mass spectrometry-based characterization of biotherapeutics and biosimilars. Agilent Technologies Inc., a US-based company, is known for offering AdvanceBio glycoenzymes.

Major companies operating in the glycomics or glycobiology market are Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., R&D Systems Inc.

North America was the largest region in the glycomics or glycobiology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the glycomics or glycobiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The glycomics or glycobiology market includes revenues earned by entities by maintaining tissue structure, porosity, and integrity. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Glycomics or Glycobiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glycomics or glycobiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glycomics or glycobiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The glycomics or glycobiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Enzymes; Kits; Reagents And Chemicals; Instruments; Carbohydrates
• 2) By Application: Drug Discovery And Development; Disease Diagnostics; Other Applications
• 3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Clinical Laboratories
• Subsegments:
• 1) By Enzymes: Glycosidases; Glycosyltransferases; Sialidases
• 2) By Kits: Glycan Analysis Kits; Glycobiology Research Kits
• 3) By Reagents And Chemicals: Monosaccharides; Oligosaccharides; Chemical Modifiers
• 4) By Instruments: Mass Spectrometers; Chromatography Systems; Imaging Systems
• 5) By Carbohydrates: Natural Carbohydrates; Synthetic Carbohydrates
• Companies Mentioned: Aligent Technologies Inc.; Bruker Corporation; Merck Co. & KgaA; New England Biolabs Inc.; Danaher Corporation; Shimadzu Corporation; ProZyme Inc.; Takara Bio Inc.; Asparia Glycomics SL; Lectenz Bio; Chemily Glycoscience LLC; Z Biotech LLC; RayBiotech Inc.; Thermo Fisher Scientific Inc.; Promega Corporation; Bio-Techne Corp.; AMS Bio LLC; Ludger Ltd.; CD BioGlyco Ltd.; GlycoDiag SAS; Kode Biotech Limited; Glyxera GmBH; Glycomix Ltd.; R&D Systems Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Glycomics or Glycobiology Market Characteristics

3. Glycomics or Glycobiology Market Trends And Strategies

4. Glycomics or Glycobiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Glycomics or Glycobiology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Glycomics or Glycobiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Glycomics or Glycobiology Market Growth Rate Analysis
• 5.4. Global Glycomics or Glycobiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Glycomics or Glycobiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Glycomics or Glycobiology Total Addressable Market (TAM)

6. Glycomics or Glycobiology Market Segmentation

• 6.1. Global Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzymes
• Kits
• Reagents and Chemicals
• Instruments
• Carbohydrates
• 6.2. Global Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery and Development
• Disease Diagnostics
• Other Applications
• 6.3. Global Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic Research Institutes
• Pharmaceutical and Biotechnology Companies
• Clinical Laboratories
• 6.4. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glycosidases
• Glycosyltransferases
• Sialidases
• 6.5. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glycan Analysis Kits
• Glycobiology Research Kits
• 6.6. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Reagents And Chemicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monosaccharides
• Oligosaccharides
• Chemical Modifiers
• 6.7. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mass Spectrometers
• Chromatography Systems
• Imaging Systems
• 6.8. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Carbohydrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Carbohydrates
• Synthetic Carbohydrates

7. Glycomics or Glycobiology Market Regional And Country Analysis

• 7.1. Global Glycomics or Glycobiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Glycomics or Glycobiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Glycomics or Glycobiology Market

• 8.1. Asia-Pacific Glycomics or Glycobiology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Glycomics or Glycobiology Market

• 9.1. China Glycomics or Glycobiology Market Overview
• 9.2. China Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Glycomics or Glycobiology Market

• 10.1. India Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Glycomics or Glycobiology Market

• 11.1. Japan Glycomics or Glycobiology Market Overview
• 11.2. Japan Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Glycomics or Glycobiology Market

• 12.1. Australia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Glycomics or Glycobiology Market

• 13.1. Indonesia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Glycomics or Glycobiology Market

• 14.1. South Korea Glycomics or Glycobiology Market Overview
• 14.2. South Korea Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Glycomics or Glycobiology Market

• 15.1. Western Europe Glycomics or Glycobiology Market Overview
• 15.2. Western Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Glycomics or Glycobiology Market

• 16.1. UK Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Glycomics or Glycobiology Market

• 17.1. Germany Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Glycomics or Glycobiology Market

• 18.1. France Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Glycomics or Glycobiology Market

• 19.1. Italy Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Glycomics or Glycobiology Market

• 20.1. Spain Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Glycomics or Glycobiology Market

• 21.1. Eastern Europe Glycomics or Glycobiology Market Overview
• 21.2. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Glycomics or Glycobiology Market

• 22.1. Russia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Glycomics or Glycobiology Market

• 23.1. North America Glycomics or Glycobiology Market Overview
• 23.2. North America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Glycomics or Glycobiology Market

• 24.1. USA Glycomics or Glycobiology Market Overview
• 24.2. USA Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Glycomics or Glycobiology Market

• 25.1. Canada Glycomics or Glycobiology Market Overview
• 25.2. Canada Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Glycomics or Glycobiology Market

• 26.1. South America Glycomics or Glycobiology Market Overview
• 26.2. South America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Glycomics or Glycobiology Market

• 27.1. Brazil Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Glycomics or Glycobiology Market

• 28.1. Middle East Glycomics or Glycobiology Market Overview
• 28.2. Middle East Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Glycomics or Glycobiology Market

• 29.1. Africa Glycomics or Glycobiology Market Overview
• 29.2. Africa Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Glycomics or Glycobiology Market Competitive Landscape And Company Profiles

• 30.1. Glycomics or Glycobiology Market Competitive Landscape
• 30.2. Glycomics or Glycobiology Market Company Profiles
  • 30.2.1. Aligent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck Co. & KgaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. New England Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Glycomics or Glycobiology Market Other Major And Innovative Companies

• 31.1. Shimadzu Corporation
• 31.2. ProZyme Inc.
• 31.3. Takara Bio Inc.
• 31.4. Asparia Glycomics SL
• 31.5. Lectenz Bio
• 31.6. Chemily Glycoscience LLC
• 31.7. Z Biotech LLC
• 31.8. RayBiotech Inc.
• 31.9. Thermo Fisher Scientific Inc.
• 31.10. Promega Corporation
• 31.11. Bio-Techne Corp.
• 31.12. AMS Bio LLC
• 31.13. Ludger Ltd.
• 31.14. CD BioGlyco Ltd.
• 31.15. GlycoDiag SAS

32. Global Glycomics or Glycobiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Glycomics or Glycobiology Market

34. Recent Developments In The Glycomics or Glycobiology Market

35. Glycomics or Glycobiology Market High Potential Countries, Segments and Strategies

• 35.1 Glycomics or Glycobiology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Glycomics or Glycobiology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Glycomics or Glycobiology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer